Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB

WHITEHEAD INSTITUTE FOR

BIOMEDICAL RESEARCH, ORDER GRANTING PLAINTIFFS’

MOTION FOR APPROVAL OF Plaintiffs,

SUPERSEDEAS BOND AND TO

14 v. STAY THE EXECUTION AND ENFORCEMENT OF COSTS

SHORELINE BIOSCIENCES, INC.,

AWARD

Defendant. [Doc. No. 439.]

18 On November 17, 2023, Plaintiffs Fate Therapeutics, Inc. (“Fate”) and Whitehead 19 Institute for Biomedical Research (“Whitehead”) filed a motion for approval of a 20 supersedeas bond and to stay the execution and enforcement of the Court’s costs award. 21 (Doc. No. 439.) On November 20, 2023, the Court took Plaintiffs’ motion under 22 submission. (Doc. No. 441.) On December 1, 2023, Defendant Shoreline Biosciences, 23 Inc. (“Shoreline”) filed a non-opposition to Plaintiffs’ motion. (Doc. No. 443.) For the 24…